Lupin launches dapagliflozin tablets 5 & 10 mg in US after FDA approval
Pharma major Lupin Ltd on Friday (April 10) has announced the launch of dapagliflozin tablets in 5 mg and 10 mg strengths in the United States. The launch follows approval of its Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (USFDA), the company said. Lupin stated that the product is bioequivalent…
